# Union for International Cancer Control

The Union for International Cancer Control (previously named International Union Against Cancer) or UICC is a non-governmental organisation with over 1,150 member organisations in more than 170 countries and territories.
UICC was founded in 1933 and is based in Geneva, Switzerland. Its member organisations feature cancer societies, governmental agencies, treatment and research centres, patient support groups and professional associations.

## History

UICC was established in Paris in 1933 following a proposal at a cancer congress in Madrid to create an international organisation that would "promote the fight against cancer through research, therapy and the development of social activities."
The organisation was given the Latin name Unio Internationalis Contra Cancrum, hence the acronym UICC, and the first General Assembly took place in Paris on 4 May 1935, with representatives from 67 national cancer organisations and 43 countries. The English name was changed in 2010 to its current name, Union for International Cancer Control so that the "UICC" acronym would be consistent with that for the French, Spanish and Latin texts.
The 1933 cancer congress in Madrid was considered the first "International Cancer Congress" and the second was held in Brussels in 1936 under the auspices of UICC. The third took place in Atlantic City, US, in 1939 before the activities of UICC were suspended due to World Word II. The fourth and fifth congresses were held in 1947 and 1950 respectively. Thereafter and until 2006, the international cancer congress – later named World Cancer Congress – and UICC’s General Assembly were held every four years; since 2006 they have been held every two years. The 2020 World Cancer Congress that was due to be held in Oman had to be called off because of the coronavirus pandemic.
The organisation moved to Geneva in 1948 to be close to the global health organisations. Today, UICC has official relations with the World Health Organization (WHO), has consultative status with the United Nations Economic and Social Council, sits on the Governing Council of the International Agency for Research on Cancer, and works closely with the Programme of Action for Cancer Therapy (PACT) initiated by the International Atomic Energy Agency.
Presidents of UICC
* 2024-2026   Ulrika Årehed Kågström (Sweden)
* 2022-2024   Prof. Jeff Dunn, AO (Australia)
* 2020–2022   Prof. Anil D’Cruz (India)
* 2018–2020   HRH Princess Dina Mired of Jordan (Jordan)
* 2016–2018   Prof. Sanchia Aranda (Australia)
* 2014–2016   Prof. Tezer Kutluk (Turkey)
* 2012–2014   Prof. Mary Gospodarowicz (Canada)
* 2010–2012   Dr Eduardo Cazap (Argentina)
* 2008–2010   Dr David Hill (Australia)
* 2006–2008   Dr Franco Cavalli (Switzerland)
* 2002–2006   Dr John Seffrin (US)
* 1998–2002   Dr E. Robinson (Israel)
* 1994–1998   Dr N. J. Gray (Australia)
* 1990–1994   Prof. S. Eckhardt (Hungary)
* 1986–1990   Prof. C. G. Schmidt (Germany)
* 1982–1986   Prof. Antonio Junqueira (Brazil)
* 1978–1982   Prof. U. Veronesi (Italy)
* 1974–1978   Prof P. Denoix (France)
* 1970–1974   Dr W. U. Gardner (US)
* 1966–1970   Dr N. N. Blokhin (USSR)
* 1962–1966   Prof. A. Haddow (United Kingdom)
* 1958–1962   Dr V. Khanolkar (India)
* 1953–1958   Prof. J. H. Maisin (Belgium)
* 1935–1953   M. J. Godart (France)

## Mission and activities

The official mission statement of UICC reads: "UICC unites and supports the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda."
Its work on cancer control includes areas such as the elimination of cervical cancer, tobacco control, metastatic breast cancer, antimicrobial resistance, cancer and ageing, access to essential medicines, equity in healthcare, Universal Health Coverage and addressing cancer care in the time of the coronavirus pandemic.
UICC convenes the cancer community at events (World Cancer Congress, World Cancer Leaders’ Summit), organises thematic webinars, provides training, fellowships and grants, and advocates for effective cancer control. It is also behind World Cancer Day, an official international awareness day marked every year on February 4.
Scientific publications
UICC published the TNM Classification of Malignant Tumors in 1953 as the "Uniform Technique for a Clinical Classification by the TNM System", with the first pocket book edition issued in 1968. The Classification has been regularly updated and the 8th edition was published with John Wiley and Sons (Wiley) in 2017.
The peer-reviewed medical journal, the International Journal of Cancer, has been the official journal of UICC since 1966 and covers topics relevant to experimental and clinical cancer research.
UICC publishes with Wiley the Manual of Clinical Oncology with information on cancer detection, diagnosis and treatment, survivorship, special populations and palliative care.
The open-access, online-only JCO Global Oncology is published in partnership with the American Society of Clinical Oncology since 2015.

## Governance

UICC is a non-governmental organisation governed by its member organisations, which meet in a general assembly held every two years. Between general assemblies a Board of Directors with 16 directors, elected at the general assembly, act as the executive body of UICC. At its head is the President of UICC, a position currently held by Prof Anil D’Cruz from India.
The organisation is managed by the CEO with a staff of some 40 employees, based in Geneva, Switzerland. The current CEO is Cary Adams, who has held this position since 2009.
Member organisations, partners and other networks
UICC’s more than 1,150 members include cancer societies, governmental agencies, treatment and research centres, patient support groups and professional associations from around the world.
UICC also works with over 60 partners, including other health organisations, foundations and private sector companies committed to reducing the global cancer burden.
In addition, UICC is a founding member of the NCD Alliance, the McCabe Centre for Law & Cancer, and the International Cancer Control Partnership UICC established the City Cancer Challenge Foundation in January 2019 and the Access to Oncology Medicines (ATOM) Coalition in 2022.